Clinical Trials Directory

Trials / Unknown

UnknownNCT05643352

Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring

Patient-reported Outcomes of Barbed Reposition Pharyngoplasty in Unilevel Palatal Snoring: a Prospective Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
AZ Delta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to determine whether there is a statistically significant difference in snoring intensity before and after performing a Barbed Reposition Pharyngoplasty as a single-level snoring procedure. The investigators aim to determine whether this is a valid alternative to the more classical techniques of pharyngoplasty. Furthermore, the investigators also wish to map the various postoperative complications and compare them with those of the more conventional techniques. The investigators compare the snoring intensity before surgery with the snoring intensity at 2 weeks (first postoperative control), at 6 weeks (second postoperative control) and at 6 months (Third postoperative control). For the evaluation of snoring, the investigators use 4 scales/questionnaires. These questionnaires are currently also used as standard at the outpatient clinic for snoring problems. These 4 scales/questionnaires are completed at every check-up. During the first postoperative check-up, the postoperative side effects are checked (bleeding, infection, readmission, needed consultation with another doctor, date of resumption of work). The investigators also map the pain with a visual analog scale and measure this the day after the operation and let the patient fill it in 3 days, 1 week and 2 weeks after the operation.

Conditions

Interventions

TypeNameDescription
PROCEDUREBarbed reposition pharyngoplastyBarbed reposition pharyngoplasty was performed in all patients

Timeline

Start date
2022-10-01
Primary completion
2022-12-01
Completion
2023-02-01
First posted
2022-12-08
Last updated
2022-12-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05643352. Inclusion in this directory is not an endorsement.